Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Arch Venture Partners Xii, Llc

10% Owner at Neumora Therapeutics, Inc. (NMRA)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-14.8%
vs. S&P 500-16.3%
Beat the market0%
Paper profit on buys−$4.1M
Total bought / sold$5.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 29SEC NMRANeumora Therapeutics, Inc. Buy 1,915,7006,046,907 held (+46%) $2.61 $5.0M -81.8%
  • Buy

    10% Owner Arch Venture Partners Xii, Llc bought $5.0M of NMRA at $2.61 — first open-market purchase in our records; raises the stake by 46%.